Bandert Anna, Lipcsey Miklós, Frithiof Robert, Larsson Anders, Smekal David
Department of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden.
Centre for Research and Development, Uppsala University/Region Gävleborg, Gävle, Sweden.
Intensive Care Med Exp. 2023 Jun 9;11(1):32. doi: 10.1186/s40635-023-00516-4.
In intensive care, different central venous catheters (CVC) are often used for infusion of drugs. If a patient is treated with continuous renal replacement therapy (CRRT) a second catheter, a central venous dialysis catheter (CVDC), is needed. Placing the catheters close together might pose a risk that a drug infused in a CVC could be directly aspirated into a CRRT machine and cleared from the blood without giving the effect intended. The purpose of this study was to elucidate if drug clearance is affected by different catheter placement, during CRRT. In this endotoxaemic animal model, an infusion of antibiotics was administered in a CVC placed in the external jugular vein (EJV). Antibiotic clearance was compared, whether CRRT was through a CVDC placed in the same EJV, or in a femoral vein (FV). To reach a target mean arterial pressure (MAP), noradrenaline was infused through the CVC and the dose was compared between the CDVDs.
The main finding in this study was that clearance of antibiotics was higher when both catheter tips were in the EJV, close together, compared to in different vessels, during CRRT. The clearance of gentamicin was 21.0 ± 7.3 vs 15.5 ± 4.2 mL/min (p 0.006) and vancomycin 19.3 ± 4.9 vs 15.8 ± 7.1 mL/min (p 0.021). The noradrenaline dose to maintain a target MAP also showed greater variance with both catheters in the EJV, compared to when catheters were placed in different vessels.
The results in this study indicate that close placement of central venous catheter tips could lead to unreliable drug concentration, due to direct aspiration, during CRRT.
在重症监护中,不同的中心静脉导管(CVC)常被用于药物输注。如果患者接受持续肾脏替代疗法(CRRT),则需要第二根导管,即中心静脉透析导管(CVDC)。将这些导管放置得很近可能会带来风险,即注入CVC的药物可能会直接被吸入CRRT机器并从血液中清除,从而无法达到预期效果。本研究的目的是阐明在CRRT期间,不同的导管放置方式是否会影响药物清除。在这个内毒素血症动物模型中,将抗生素注入置于颈外静脉(EJV)的CVC中。比较了CRRT通过置于同一EJV或股静脉(FV)的CVDC时的抗生素清除情况。为了达到目标平均动脉压(MAP),通过CVC输注去甲肾上腺素,并比较了不同CVDC之间的剂量。
本研究的主要发现是,在CRRT期间,与导管位于不同血管相比,当两个导管尖端都在EJV且靠得很近时,抗生素清除率更高。庆大霉素的清除率为21.0±7.3 vs 15.5±4.2 mL/min(p = 0.006),万古霉素为19.3±4.9 vs 15.8±7.1 mL/min(p = 0.021)。与导管置于不同血管时相比,当两个导管都在EJV时,维持目标MAP所需的去甲肾上腺素剂量也显示出更大的差异。
本研究结果表明,在CRRT期间,中心静脉导管尖端放置过近可能会因直接抽吸导致药物浓度不可靠。